To identify mitochondrial haplogroups that confer resistance against or susceptibility to metabolic syndrome, we performed a large-scale association study on 1,337 unrelated Japanese individuals, including 871 subjects with metabolic syndrome and 466 control subjects. 
M
etabolic syndrome is a complex, multifactorial disorder in which interactions among various genetic and environmental influences play an important role. Metabolic syndrome is characterized by visceral obesity, hyperlipidemia, hypertension, and hyperglycemia and is pathophysiologically linked with insulin resistance. Persistence of these features of metabolic syndrome leads to the development of atherosclerosis and type 2 diabetes and, finally, to cardiovascular and cerebrovascular events that result in disability and even death. Mitochondrial dysfunction is postulated to be involved in both insulin resistance in the skeletal muscle and impaired insulin secretion from pancreatic ␤-cells (1) .
Maternally inherited variations in the mitochondrial genome have resulted from the sequential addition of new mutations during the expansion of Homo sapiens from Africa to Asia and Europe over the last 200,000 years (2) . Because the mutational rate of the mitochondrial genome is ϳ10 times higher than that of the nuclear genome, the ancient mitochondrial polymorphisms that have accumulated during the relatively short history of Homo sapiens may contribute to the metabolic characteristics of modern humans (3) . It is reasonable to speculate that the mitochondrial haplogroups detected in various regions of the world have been selected through the adaptation to cold climates and nutritional conditions (3) (4) (5) . Lines of evidence supporting functional differences among mitochondrial haplogroups have been provided by studies on sperm motility (6), survival rate after sepsis (7), and susceptibility to Parkinson's disease (8) .
In earlier studies we aimed to identify mitochondrial single nucleotide polymorphisms (mtSNPs) associated with age-related conditions, such as longevity (9) , Parkinson's disease (10, 11) , and Alzheimer's disease, with those related to energy metabolism, such as obesity (12) , thinness (13) , and type 2 diabetes (12), or with atherosclerosis. For this purpose, we sequenced the entire mitochondrial genome of 672 individuals (14) . From our findings we constructed a human mtSNP database (http://www.giib. or.jp/mtsnp/index_e.shtml). On the basis of this database we have developed a comprehensive mtSNP analysis system by use of fluorescent beads. We have now performed a large-scale association study on metabolic syndrome and 10 major haplogroups (F, B, A, N9a, M7a, M7b, G1, G2, D5, and D4) in Japan based on the comprehensive analysis of mtSNPs. Our aim was to predict the genetic risk for metabolic syndrome and thereby contribute to the primary prevention of this condition.
ference. On the basis of the recent recognition of a need to revise BMI criteria for obesity in Japanese and other Asian populations (18), we set the cutoff point for obesity as a BMI of Ն25 kg/m 2 . Participants were thus diagnosed with metabolic syndrome if they had three or more of the following five components: 1) a BMI of Ն25 kg/m 2 , 2) a serum concentration of triglycerides of Ն1.65 mmol/l (150 mg/dl), 3) a serum concentration of HDL cholesterol of Ͻ1.04 mmol/l (40 mg/dl) for men or Ͻ1.30 mmol/l (50 mg/dl) for women, 4) a systolic blood pressure of Ն130 mmHg and diastolic blood pressure of Ն85 mmHg, and 5) a fasting plasma glucose level of Ն6.05 mmol/l (110 mg/dl). On the basis of these criteria, 871 subjects (584 men, 287 women) were diagnosed with metabolic syndrome. The control subjects comprised a total of 466 individuals (299 men, 167 women) who visited the outpatient clinics of the participating hospitals for an annual health checkup. They had none of the five criteria of metabolic syndrome described above or any history of obesity, hyperlipidemia, dyslipidemia, hypertension, or diabetes. Individuals with metabolic or endocrinologic diseases or those taking drugs that cause secondary diabetes were excluded from the study. The study protocol was approved by the Committee on the Ethics of Human Research of Gifu International Institute of Biotechnology, and informed consent was obtained from each participant. Selection of mitochondrial polymorphisms for haplogroup classification. With the use of our human mtSNP database (http://www.giib.or.jp/ mtsnp/index_e.shtml) and the phylogenetic tree of Japanese (14), we selected 149 polymorphic sites that have been useful for classification of mitochondrial haplogroups. We further selected 25 mtSNPs that define 10 major haplogroups (A, B, D4, D5, F, G1, G2, N9a, M7a, and M7b) found in the Japanese population (Supplementary Table 1 , available at http://dx.doi.org/10.2337/db06-1105). We examined the relationship between these haplogroups and metabolic syndrome in the 1,337 participants of the present study. Genotyping of polymorphisms. Total DNA was extracted from blood samples, and fragments of mitochondrial DN (mtDNA) were amplified from the total DNA by 28-plex PCR. Mitochondrial polymorphisms were determined with sequence-specific oligonucleotide probes by use of suspension array technology (Luminex 100; Luminex, Austin, TX). Detailed methodology for genotyping was described in the legend for Supplementary Table 1 . Statistical analysis. Quantitative clinical data were compared between patients with metabolic syndrome and control subjects by the unpaired Student's t test. Qualitative data were compared by the 2 test. We performed multivariate logistic regression analysis to adjust risk factors, with metabolic syndrome as a dependent variable and independent variables including age, sex, smoking status, and genotype of each mtSNP. The P value, odds ratio (OR), and 95% CI were calculated. Unless indicated otherwise, a P value of Ͻ0.05 was considered statistically significant. Because of multiple comparisons of haplogroups, we applied Bonferroni's correction. Since we examined 10 haplogroups, we divided 0.05 by 10 to get 0.005. Thus, a P value of Ͻ0.005 was considered statistically significant.
RESULTS
The characteristics of the 1,337 subjects are shown in Table 1 . Neither age nor female-to-male ratio was different between subjects with metabolic syndrome and control subjects. BMI, triglycerides, fasting plasma glucose concentration, and A1C were significantly higher in subjects with metabolic syndrome than in control subjects. HDL cholesterol was significantly lower in metabolic syndrome subjects than in control subjects. The prevalences of smoking, hypertension, hypercholesterolemia, and diabetes were significantly higher in subjects with metabolic syndrome than in control subjects.
Multivariate logistic regression analysis with adjustment for age, sex, and smoking status revealed that the mitochondrial haplogroup N9a was related to resistance against metabolic syndrome and that three haplogroups, i.e., N9a, G1, and D5, were related to resistance against metabolic syndrome in women (Table 2) , on the basis of a P value of Ͻ0.05. However, because of the multiple comparisons of haplogroups, we considered a P value of Ͻ0.005 to be significant for such associations. On the basis of this criterion, the haplogroup N9a was significantly associated with resistance against metabolic syndrome for women.
A stepwise forward selection procedure revealed that 
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Data are means Ϯ SD or percent. *Defined as smoking Ն10 cigarettes/day. †Defined as having systolic blood pressure Ն140 mmHg or diastolic blood pressure Ն90 mmHg, both, or taking antihypertensive medication. ‡Defined as having serum total cholesterol Ն220 mg/dl (5.72 mmol/l) or taking lipid-lowering medication. §Defined as having fasting blood glucose Ն126 mg/dl (6.93 mmol/l) or A1C Ն6.5%, both, or taking antidiabetic medication.
haplogroup N9a is a protective factor against metabolic syndrome (Table 3) . For men, however, none of these haplogroups were associated with metabolic syndrome. For women, a stepwise forward selection procedure revealed that age and haplogroups N9a, G1, and D5 were independent risk or protective factors against metabolic syndrome. The total contribution of haplogroups N9a, G1, and D5 to protection against metabolic syndrome was 0.0361, suggesting that mitochondrial genome polymorphisms are important genetic factors influencing the susceptibility to metabolic syndrome for women.
DISCUSSION
We examined the relationship between metabolic syndrome and each of 10 major mitochondrial haplogroups in a large-scale association study of 1,337 individuals. Three of these haplogroups, i.e., N9a, G1, and D5, were significantly associated with resistance against metabolic syndrome in women. The present observation in Japanese subjects need to be replicated in other populations to confirm whether these haplogroups influence metabolic characteristics of individuals. In the present study, we adopted the criteria of BMI Ն25 kg/m 2 instead of waist circumference. If we adopt different criteria of metabolic syndrome, relations of mitochondrial haplogroups to this condition might differ from those observed in the present study.
Most of the mtSNPs characteristic of haplogroup N9a are synonymous mutations including 5231G3 A and 12372G3 A, which were used for the present genotyping. Possible candidates for functional polymorphisms in this haplogroup are 150C3 T and 338C3 T, which are in the noncoding region of the mitochondrial genome. The 150C3 T replacement was originally reported in Italian centenarians (19) . Also, we reported this replacement to be associated with healthy longevity in both Finland and Japan (20) . Thus, the 150C3 T might confer resistance against metabolic syndrome in women.
Among haplogroup N9a-specific mtSNPs, the 12358A3 G causing the Thr8Ala replacement in the NADH dehydrogenase subunit 5 (ND5) would seem to be one of the potentially functional polymorphisms (Supplementary Tables 5 and 6). This subunit seems to be essential for the function of Complex I, because various missense mutations in the ND5 gene have been reported in mitochondrial diseases. Therefore, it seems possible that the Thr8Ala replacement caused by the 12358A3 G might also affect the function of the ND5 subunit and Complex I. The actual effect of the mtSNP 12358A3 G (ND5: T8A) on mitochondrial function remains to be examined.
Among the mtSNPs characteristic of haplogroup G1, the 15497G3 A (Cytb: G251S) seems to be a functional polymorphism. Our previous survey as a part of the National Institute for Longevity Longitudinal Study on Aging revealed that the 15497G3 A (Cytb: G251S) was associated with obesity in a middle-aged and elderly Japanese population (21) . This observation suggests that the 15497A is associated with simple obesity without hypertension, hyperglycemia, or hypercholesterolemia, which are components of metabolic syndrome. Thus, the present result showing that the haplogroup G1 with 15497A conferred resistance against metabolic syndrome is consistent with our previous observation that the metabolism of both glucose and cholesterol is relatively normal in women with the 15497A allele (21) .
In our previous study, we reported that haplogroup D, characterized by the 5178C3 A (ND2: L237M) polymorphism, is associated with longevity and that this polymorphism confers resistance against age-related diseases (9) . In addition to the 5178C3 A, individuals with haplogroup D5 carry the 150C3 T transition in the noncoding region of their mitochondrial genome. We recently reported that the 150C3 T transition was more frequently detected in both Japanese centenarians and the Finnish nanogerians (Ͼ90 years) than in the respective control populations (20) . The protective effect of haplogroup D5 against metabolic syndrome reported here is consistent with our previous observation that the 150C3 T is associated with longevity.
Because there are no recombination mechanisms in mitochondria, all of the mtSNPs in each haplogroup or subhaplogroups are tightly linked to each other. Therefore, it is possible that some of the mtSNPs examined in our present study are in linkage disequilibrium with functional polymorphisms of other mitochondrial genes that are actually responsible for the resistance against metabolic syndrome. For women, haplogroups N9a, G1, and D5 were associated with resistance against metabolic syn- drome, whereas these associations were not detected in men. There is other evidence supporting the idea that the association of genetic variation with obesity is stronger in women than in men (22, 23) . As shown in Table 2 , old age was associated with an increased risk for metabolic syndrome in women, whereas younger age was associated with an increased risk for this condition in men. This difference in the effect of age on the risk of metabolic syndrome between women and men might provide us a clue to understand the sex difference in the effects of mitochondrial haplogroups. The possible cause of metabolic syndrome in women would be related to the biologically defined and age-dependent decrease in tissue metabolisms. In men, the cause of metabolic syndrome might be related to extrinsic factors, such as smoking, satiety, and physical inactivity. These differences might explain the present observation that women but not men were distinctly influenced by the differences among mitochondrial haplogroups. Several association studies have previously examined the relationship between nuclear gene polymorphisms and metabolic syndrome. Yamada et al. (24) showed that a nuclear single nucleotide polymorphism in the promoter region of the apolipoprotein A-V gene is associated with metabolic syndrome. Genotyping of these mtSNPs and nuclear single nucleotide polymorphisms may prove informative for predicting the genetic risk for metabolic syndrome and may thereby contribute to the primary prevention of metabolic syndrome.
